African Vaccine Acquisition Task Team

African Vaccine Acquisition Task Team
Name	African Vaccine Acquisition Task Team
Formation	2020
Founders	African Union, AATK allies
Type	Initiative
Location	Addis Ababa, South Africa
Region served	Africa

African Vaccine Acquisition Task Team

The African Vaccine Acquisition Task Team was a continent-wide initiative established in 2020 to coordinate vaccine procurement and delivery across Africa, engaging a broad coalition including continental institutions, regional economic communities, and international partners. The initiative operated at the nexus of public health diplomacy between entities such as the African Union, World Health Organization, Gavi, the Vaccine Alliance, and bilateral partners including European Union member states and the United States. It played a central role during the COVID-19 pandemic in negotiating supply deals, managing logistics, and mobilizing finance.

Background and formation

The task team emerged amid the global scramble for COVID-19 pandemic countermeasures, responding to inequities highlighted during negotiations involving COVAX, Serum Institute of India, Pfizer–BioNTech, Moderna, and AstraZeneca. Leaders from African Union member states, including representatives from South Africa, Nigeria, Kenya, Ethiopia, and Egypt, convened with institutions such as the African Centres for Disease Control and Prevention, New Partnership for Africa's Development, and African Export-Import Bank to create a pooled procurement mechanism. The formation was influenced by precedent initiatives like the Pan American Health Organization procurement efforts and lessons from the Ebola virus epidemic in West Africa.

Objectives and mandate

The primary mandate focused on securing timely access to safe and effective vaccines from manufacturers including Johnson & Johnson, Sinopharm, Sinovac, Sputnik V, and Novavax for member states. Secondary objectives included strengthening regulatory harmonization with bodies such as the African Medicines Agency, coordinating with the World Bank and International Monetary Fund on financing, and advancing local production via partners including Biovac and manufacturing hubs in South Africa and Senegal. The task team sought to align procurement with immunization strategies of United Nations Children's Fund and surveillance by Africa CDC.

Governance and organizational structure

Governance combined representation from the African Union Commission, technical leadership from the Africa Centres for Disease Control and Prevention, and advisory inputs from international organizations like World Health Organization and Gavi, the Vaccine Alliance. A steering committee included finance experts connected to the African Export-Import Bank and policy specialists from regional blocks such as the Economic Community of West African States and the Southern African Development Community. Operational arms liaised with national immunization programs in Rwanda, Ghana, Tanzania, Uganda, and Morocco, while procurement teams negotiated with manufacturers in India, China, Russia, and United States markets.

Procurement operations and vaccine portfolio

Procurement operations combined advance purchase agreements, pooled orders, and facility-based contracts with suppliers like AstraZeneca, Johnson & Johnson, Pfizer–BioNTech, Moderna, and Chinese producers. The portfolio included viral vector vaccines, mRNA vaccines, inactivated vaccines, and protein subunit candidates such as those from Novavax. Negotiations involved logistics partners including DHL, cold chain providers with ties to UNICEF, and financing instruments coordinated with the World Bank and European Investment Bank. The task team also explored licenses and technology transfers through partnerships with entities like Biovac and academic hubs including University of Cape Town research units.

Funding and partnerships

Funding sources blended contributions from African Union member states, multilateral loans from the World Bank, grants from Bill & Melinda Gates Foundation, and procurement guarantees supported by European Union facilities. Strategic partnerships included Gavi, the Vaccine Alliance, UNICEF, World Health Organization, and bilateral donors such as United States Agency for International Development and the governments of United Kingdom, Germany, and France. Private sector engagement included logistics companies and pharmaceutical distributors operating in markets including Nigeria, Kenya, South Africa, and Egypt.

Distribution, logistics, and cold chain

Distribution planning required coordination with regional logistics hubs in Addis Ababa, Johannesburg, Accra, and Abidjan, and utilized air freight corridors linking to airports such as O. R. Tambo International Airport and Bole International Airport. Cold chain management relied on partnerships with UNICEF supply divisions, refrigeration firms, and national Expanded Programme on Immunization teams in countries like Ghana, Senegal, Zambia, and Botswana. The task team addressed last-mile challenges through collaboration with Médecins Sans Frontières operations, faith-based health networks, and civil society organizations in urban centers such as Lagos and Nairobi.

Impact, challenges, and criticism

Impact included accelerating deliveries that supplemented allocations from COVAX Facility, enabling vaccine access in nations including Rwanda, Seychelles, Mauritius, and Gabon, and catalyzing nascent manufacturing projects in South Africa and Senegal. Challenges encompassed supply shortfalls caused by export restrictions in India, intellectual property debates involving World Trade Organization discussions, cold chain constraints in rural Democratic Republic of the Congo and Mali, and variable national uptake influenced by misinformation amplified on platforms such as Twitter and Facebook. Criticism came from civil society groups, academic commentators at institutions like London School of Hygiene & Tropical Medicine and Harvard University, and some member states over transparency of contracts, pricing, and allocation criteria. The effort influenced subsequent policy dialogues on regional pharmaceutical manufacturing, medical product regulation via the proposed African Medicines Agency, and continental health security integration within African Union frameworks.

Category:Health in Africa